STOCK TITAN

REGENCY CENTERS CORP (REG) SEC Filings, Feb 17-20, 2026

REG NASDAQ

Welcome to our dedicated page for REGENCY CENTERS SEC filings (Ticker: REG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on REGENCY CENTERS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into REGENCY CENTERS's regulatory disclosures and financial reporting.

Rhea-AI Summary

REG submitted Form 144 notices reporting proposed sales of up to 10,000 common shares. The filing lists vested restricted shares of 9,175 shares vested 02/04/2026 (services rendered) and 825 shares vested 03/06/2015 (services rendered).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Regency Centers, L.P. is offering $450,000,000 of 4.50% Notes due March 15, 2033, with interest payable semi-annually on March 15 and September 15, beginning September 15, 2026. The notes are guaranteed by Regency Centers Corporation and were priced at 99.376% of par.

The issuer expects net proceeds of approximately $443.3 million, which will be used to reduce borrowings under its line of credit, repay the $100 million aggregate principal amount of the 2026 Notes at maturity and for general corporate purposes. Delivery is expected on or about February 23, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Regency Centers, L.P. is offering a series of unsecured notes guaranteed by Regency Centers Corporation, with interest payable semi-annually beginning in 2026 and initial denominations of $2,000 and integral multiples of $1,000 thereafter. The notes will be issued under Regency’s indenture and may be redeemed at the issuer’s option under the terms disclosed.

The prospectus supplement dated February 18, 2026 describes permitted uses of net proceeds, including repayment of $100 million aggregate principal amount of the 2026 Notes, reduction of borrowings under the line of credit and general corporate purposes such as capital expenditures and development projects.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
Rhea-AI Summary

Regency Centers Corporation entered into a new Equity Distribution Agreement and forward master confirmation with RBC Capital Markets and Royal Bank of Canada, adding them as a sales agent, forward seller and forward purchaser under its existing at-the-market equity program for common stock. The combined Equity Distribution Agreements permit offers and sales of shares of common stock from time to time having an aggregate offering price of up to $500,000,000. The structure allows Regency Centers to sell shares directly through sales agents or indirectly via forward sale agreements, with sales agents and forward sellers earning commissions of up to 2.0% of the gross sales price. Regency expects to primarily physically settle forward sales to receive cash proceeds later, but it may also choose cash or net share settlement, which could require delivering cash or shares to the forward purchasers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Regency Centers Corporation is registering the offer and sale of up to $500,000,000 of its common stock through an ongoing at‑the‑market equity distribution program. The stock may be sold from time to time via multiple sales agents and through forward sale agreements with several major banks.

The company can issue shares directly or have forward purchasers borrow and sell shares as forward sellers, with total sales under the program capped at an aggregate sales price of $500,000,000. Net proceeds from direct issuances and physical settlement of forward sale agreements are intended to fund development and redevelopment projects, potential acquisitions, repayment of revolving credit facility borrowings and other debt, and general corporate purposes.

Regency notes that forward sale agreements may be physically, cash or net share settled, which can create dilution to earnings per share and return on equity or result in cash obligations. The filing also highlights REIT‑specific tax risks if significant gains from cash‑settled forwards were to affect REIT income tests, as well as broader dilution and stock‑price pressure risks from issuing additional common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

A security holder filed a Form 144/A notice to potentially sell 15,000 shares of common stock, with an aggregate market value of $1,135,800. The proposed sale, through Charles Schwab Corp on NASDAQ, is targeted for around 02/09/2026.

These 15,000 shares were acquired on 02/10/2023 directly from the issuer as equity compensation, rather than a cash purchase. Shares outstanding were reported at 182,900,978; this is a baseline figure, not the planned sale amount. No sales over the past three months are listed for this holder.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Regency Centers Corp officer Devereaux Terah L, the Principal Accounting Officer, reported several equity-related transactions on February 12, 2026. The filing shows the exercise or conversion of derivative awards into 3,506 shares of Common Stock, partly linked to restricted stock vesting and dividend equivalents.

The report also shows a tax-withholding disposition of 1,479 shares of Common Stock at $73.40 to cover obligations tied to these awards. After these transactions, Devereaux Terah L directly owned 19,230 shares of Common Stock and 8,051 shares of Restricted Stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Regency Centers Corporation Senior VP and General Counsel Michael R. Herman reported equity award activity on February 12, 2026. He acquired 7,459 shares of common stock through the vesting and conversion of restricted stock and related dividend equivalents.

To cover tax obligations, 2,807 common shares were disposed of at $73.40 per share, leaving him with 21,601 common shares held directly and 4,257 shares of restricted stock. The company notes that a prior report understated his restricted stock grant by 538 shares, now correctly reflected as of February 17, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

STEIN MARTIN E JR reported multiple insider transaction types in a Form 4 filing for REG. The filing lists transactions totaling 36,566 shares at a weighted average price of $73.40 per share. Following the reported transactions, holdings were 10,081 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Regency Centers Corp President and CEO Lisa Palmer reported equity award activity. On February 12, 2026, she acquired 82,877 shares of common stock through the vesting and conversion of performance shares, restricted stock, and related dividend equivalents. On the same date, she disposed of 32,625 shares at $73.40 per share to satisfy tax withholding obligations. After these transactions, she directly owned 157,942 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many REGENCY CENTERS (REG) SEC filings are available on StockTitan?

StockTitan tracks 107 SEC filings for REGENCY CENTERS (REG), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for REGENCY CENTERS (REG)?

The most recent SEC filing for REGENCY CENTERS (REG) was filed on February 20, 2026.